Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis

PHASE3CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

March 31, 2017

Conditions
ThrombophlebitisPhlebitis
Interventions
DRUG

Hirudoid cream 0.3 % Mucopolysaccharide polysulfate

Hirudoid cream

DRUG

Placebo cream without active substance

Trial Locations (4)

107000

Siriraj Hospital, Bangkok

Unknown

Chulalongkorn Hospital, Bangkok

Rajvithi Hospital, Bangkok

Bamrasnaradua Infectious Diseases Institute, Nonthaburi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medinova AG

INDUSTRY

NCT01943006 - Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis | Biotech Hunter | Biotech Hunter